New Medicines, Novel Insights: Advancing rare disease drug development

Novel therapies for rare diseases offer hope for thousands of patients and their families. This interactive report presents insights from Parexel experts doing everything humanly possible to deliver on the promise of patient-focused drug development – and to bring more rare disease treatments to market, faster.

Explore the report

 

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Video

How to transition existing trials under EU-CTR

Feb 1, 2023

Podcast

Why Rare Disease Therapeutics Need Early Market Access Planning

Jan 4, 2023

Video

The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?

Feb 1, 2023

Article

Bringing clinical trials to patients with the decentralized model

Jan 8, 2021

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023